Clinical Trial Update: Efficacy and Safety of Fruquintinib With Sintilimab as First-line Therapy in Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fruquintinib with sintilimab as first-line therapy for stomach cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Stomach Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)
• Sintilimab (sintilimab)

Snippet

Sponsor: RenJi Hospital | Conditions: Stomach Neoplasms | Phase 2 | Status: UNKNOWN